3 results
Primary Objective: to explore whether UVB exposure leads to detectable changes of the biomarkers of the skin barrier, immune response and DNA-damage in urine and stratum corneum Secondary Objective(s): to explore the profile of biomarkers in…
This study will evaluate the efficacy of brentuximab vedotin in combination with lenalidomide and rituximab among subjects with relapsed or refractory CD30-positive (CD30 expression >=1%) or CD30 <1% (CD30 expression <1%) DLBCL.
The primary objectives of this study are:1) To investigate the feasibility of the GISMO GEN1 System to monitor biomarkers in the gastrointestinal tract by studying the ingestible transit time, data coverage, participant experience, and serious…